NEW DELHI: In a pandemic situation, emergency use of vaccinations is considered based on safety and immunogenicity data while phase three clinical trial It is underway, the head of the Indian Council for Medical Research (ICMR), Balram Bhargava, said on Tuesday. Explaining the process followed to grant approval to the …
Read More »During the pandemic, restricted use of the vaccine was considered based on safety and immunogenicity data: Head of ICMR | India News
